Cargando…
New advances in the development of a vaccine against paracoccidioidomycosis
Paracoccidioidomycosis (PCM) is an endemic Latin American mycosis caused by Paracoccidioides brasiliensis and also by the recently described P. lutzii. The systemic mycosis is the 10th leading cause of death due to infectious diseases in Brazil. As published, 1,853 patients died of PCM in the 1996–2...
Autores principales: | Travassos, Luiz R., Taborda, C. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373149/ https://www.ncbi.nlm.nih.gov/pubmed/22701452 http://dx.doi.org/10.3389/fmicb.2012.00212 |
Ejemplares similares
-
The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide
por: Mayorga, Oriana, et al.
Publicado: (2012) -
PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE
AGAINST AN ENDEMIC MYCOSIS IN THE AMERICAS
por: TABORDA, Carlos. P., et al.
Publicado: (2015) -
Therapeutic DNA Vaccine Encoding Peptide P10 against Experimental Paracoccidioidomycosis
por: Rittner, Glauce M. G., et al.
Publicado: (2012) -
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
por: Silva, Leandro B. R., et al.
Publicado: (2017) -
Experimental Therapy of Paracoccidioidomycosis Using P10-Primed Monocyte-Derived Dendritic Cells Isolated From Infected Mice
por: Silva, Leandro B. R., et al.
Publicado: (2019)